載入...
Practice Variations in the Use of Novel Oral Anticoagulants for Nonvalvular Atrial Fibrillation-Related Stroke among Stroke Neurologists in Saudi Arabia
Clinical trials have demonstrated that novel oral anticoagulants (NOACs) are noninferior to warfarin in preventing nonvalvular atrial fibrillation- (nvAF-) related stroke and systemic embolism. However, in these trials, NOACs initiation was delayed for a variable period after stroke. Herein, we aime...
Na minha lista:
| 發表在: | Neurol Res Int |
|---|---|
| Main Authors: | , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Hindawi
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6721244/ https://ncbi.nlm.nih.gov/pubmed/31531241 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/5373250 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|